Brain Integrity in Survivors of Hodgkin Lymphoma Treated With Thoracic Radiation
Brain Integrity in Survivors of Hodgkin Lymphoma (HL) Treated With Thoracic Radiation
While thoracic radiation therapy (TRT) has been a primary component in successful treatment of a variety of childhood and adult cancers, the exposure to this treatment has been associated with significant cardiovascular and pulmonary morbidity in long-term survivors. Within non-cancer populations, cardiovascular and pulmonary morbidity is associated with increased risk for cerebral vascular accidents (CVAs), accelerated brain atrophy and neurocognitive impairment. Patients with chronic heart disease demonstrate problems with attention, processing speed, memory, and executive functions. Chronic pulmonary disease also increases the risk of stroke, leukoencephalopathy, and neurocognitive impairment in non-cancer populations. The investigators propose to examine indices of brain integrity, including neurocognitive performance and brain MRI/MRA, in long-term adult survivors of Hodgkin lymphoma (HL) treated with thoracic radiation and no direct central nervous system therapy.
OBJECTIVES:
- To evaluate brain integrity in adult survivors of childhood HL treated with thoracic radiation therapy.
- To identify therapeutic factors associated with brain integrity in adult survivors of childhood HL who are at risk for cardiac and pulmonary morbidity.
- To examine associations between cardiac, vascular and pulmonary health and brain integrity in adult survivors of childhood HL treated with thoracic radiation.
연구 개요
상태
정황
상세 설명
This is an observational study to collect health data from long-term survivors of Hodgkin lymphoma (HL). Data will be collected once at participant enrollment. The long-term effects of thoracic radiation therapy (TRT) given earlier as part of the treatment for HL will be examined in long-term survivors and compared to health data collected from normal volunteers.
HL survivors who were treated at St. Jude Children's Research Hospital (SJCRH) with TRT will be recruited to complete a comprehensive neurocognitive evaluation, brain MRI/MRA, a clinical neurological exam, peripheral pulse contour analysis, non-invasive central blood pressure monitoring, cardiopulmonary exercise testing, and serum biomarkers related to cardiac disease. As part of their standard St. Jude LIFE protocol evaluation, they also complete an echocardiogram, pulmonary function tests and questionnaires designed to evaluate broad health, psychological, socioeconomic and environmental factors that impact everyday life.
A comparison sample of healthy individuals, frequency-matched on age, sex and race will also be recruited. The comparison group will complete the comprehensive neurocognitive evaluation, brain MRI/MRA, clinical neurological exam, pulse contour analysis, non-invasive central blood pressure monitoring, and cardiopulmonary exercise testing. Through the St. Jude LIFE protocol, the comparison sample will also complete an echocardiogram, pulmonary function tests and questionnaires designed to evaluate broad health, psychological, socioeconomic and environmental factors that impact everyday life.
연구 유형
등록 (실제)
연락처 및 위치
연구 장소
-
-
Tennessee
-
Memphis, Tennessee, 미국, 38105
- St. Jude Children's Research Hospital
-
-
참여기준
자격 기준
공부할 수 있는 나이
건강한 자원 봉사자를 받아들입니다
연구 대상 성별
샘플링 방법
연구 인구
SJLIFE is an institutional initiative to establish a lifetime survivor cohort to study physical and behavioral health outcomes in adult survivors of childhood cancer. This protocol includes individuals diagnosed and treated with a malignancy during childhood at SJCRH since 1962, who are now 10 or more years from diagnosis and over 18 years of age.
The current study will recruit participants from the SJLIFE cohort who received thoracic radiation as part of their treatment for Hodgkin lymphoma.
Potentially eligible comparison group participants will be recruited from the relative or friend population who accompany any After Completion of Therapy (ACT) or SJLIFE patient for follow-up at SJCRH.
설명
Inclusion Criteria - HL participant:
- Current St. Jude LIFE protocol Participant, treated with thoracic radiation
- Currently ≥ 18 years of age
- ≥ 10 years from original diagnosis
Exclusion Criteria - HL participant:
- Has participated in the previous pilot study at St. Jude (HPP16)
- History of cranial or total-body radiation therapy
- History of intrathecal Methotrexate, high-dose Methotrexate or high-dose Cytarabine.
- History of head injury or diagnosis of a genetic disorder associated with neurocognitive impairment
- Pre-existing known neurocognitive impairment prior to diagnosis of Hodgkin lymphoma
- History of congenital heart disease reported in the literature to be associated with neurocognitive status as determined by the principal investigators
- Currently pregnant
- Secondary central nervous system neoplasm
Inclusion Criteria - Normal Control:
- Research participant is a sibling, parent, relative or friend of a current or former St. Jude patient
- Research participant must be at least 18 years of age at the time of the scheduled evaluation
Exclusion Criteria - Normal Control:
- History of cranial, total-body or thoracic radiation therapy
- History of intrathecal Methotrexate, high-dose Methotrexate, or high-dose Cytarabine.
- History of head injury or diagnosis of a genetic disorder associated with neurocognitive impairment
- Known neurocognitive impairment
- History of congenital heart disease reported in the literature to be associated with neurocognitive status as determined by the principal investigators
- Currently pregnant
- Central nervous system neoplasm
공부 계획
연구는 어떻게 설계됩니까?
디자인 세부사항
- 관찰 모델: 케이스 컨트롤
- 시간 관점: 다른
코호트 및 개입
그룹/코호트 |
개입 / 치료 |
|---|---|
|
Hodgkin lymphoma
Participants previously treated at St. Jude Children's Research Hospital with thoracic radiation therapy for Hodgkin lymphoma. Interventions: Neurocognitive Evaluation, Quantitative Brain Imaging, Neurologic Evaluation, Comprehensive Health Questionnaire, Vascular Testing, Cardiopulmonary Exercise Testing, Echocardiography, Pulmonary Function Testing, Serum Biomarkers, and Ophthalmology Examination. |
The neurocognitive evaluation will include measures of academic achievement, intelligence, sustained attention, memory, processing speed, executive functions, functional behavior, and emotional functioning.
Imaging will include raw images to both quantify white matter hyperintensities and hemosiderin deposits, as well as cortical thickness and tissue segmentation.
Brain imaging will be repeated on participants who are concurrently enrolled on BRIGHT and MIND protocols at St. Jude and who completed prior brain imaging during the BRIGHT clinic visit.
The repeat MRI will be done at their 6 month MIND clinic visit.
Evaluation includes a complete review of neurologic symptoms, and interview and examination by the neurologist, assessment of neurologic symptoms and determination of their impact on day-to-day living, and quantified neurologic examination by the neurologist.
Participants will be asked to complete an approximately 450-item survey to assess health history and status, social and demographic factors, health behaviors, and psychosocial constructs.
Digital assessment of endothelial function will be studied, and central blood and pulse pressure and carotid-femoral pulse wave velocity will be non-invasively measured.
Study participants will undergo cardiopulmonary exercise testing by treadmill.
Those participants whose physical performance does not permit walking safely on the treadmill (extreme deconditioning, lower extremity paralysis, balance disorder, acute lower extremity injury) will perform cardiopulmonary exercise testing on a bicycle or upper extremity ergometer using a comparable testing protocol.
A complete 3D as well as 2D echocardiogram with Doppler and M-mode will be performed.
Pulmonary function testing will include spirometry, lung volume measurements by body plethysmography, and single-breath carbon monoxide-diffusion capacity (DLCO).
Blood for serum biomarkers associated with cardiovascular morbidity will be drawn, including high-sensitivity C-reactive protein, serum homocysteine.
Ophthalmology examination will include a review of symptoms, examination, and fundus imaging.
The examination will consist of visual acuity testing, refraction testing, retinoscopy, ocular pressure, and examination under mydriasis.
Fundus photography will be used to capture an image of the retina for examination of potential hypertensive retinopathy.
|
|
Normal control
A group of healthy individuals matched for age, sex and race. Interventions: Neurocognitive Evaluation, Quantitative Brain Imaging, Neurologic Evaluation, Comprehensive Health Questionnaire, Vascular Testing, Cardiopulmonary Exercise Testing, Echocardiography, Pulmonary Function Testing, Serum Biomarkers, and Ophthalmology Examination. |
The neurocognitive evaluation will include measures of academic achievement, intelligence, sustained attention, memory, processing speed, executive functions, functional behavior, and emotional functioning.
Imaging will include raw images to both quantify white matter hyperintensities and hemosiderin deposits, as well as cortical thickness and tissue segmentation.
Brain imaging will be repeated on participants who are concurrently enrolled on BRIGHT and MIND protocols at St. Jude and who completed prior brain imaging during the BRIGHT clinic visit.
The repeat MRI will be done at their 6 month MIND clinic visit.
Evaluation includes a complete review of neurologic symptoms, and interview and examination by the neurologist, assessment of neurologic symptoms and determination of their impact on day-to-day living, and quantified neurologic examination by the neurologist.
Participants will be asked to complete an approximately 450-item survey to assess health history and status, social and demographic factors, health behaviors, and psychosocial constructs.
Digital assessment of endothelial function will be studied, and central blood and pulse pressure and carotid-femoral pulse wave velocity will be non-invasively measured.
Study participants will undergo cardiopulmonary exercise testing by treadmill.
Those participants whose physical performance does not permit walking safely on the treadmill (extreme deconditioning, lower extremity paralysis, balance disorder, acute lower extremity injury) will perform cardiopulmonary exercise testing on a bicycle or upper extremity ergometer using a comparable testing protocol.
A complete 3D as well as 2D echocardiogram with Doppler and M-mode will be performed.
Pulmonary function testing will include spirometry, lung volume measurements by body plethysmography, and single-breath carbon monoxide-diffusion capacity (DLCO).
Blood for serum biomarkers associated with cardiovascular morbidity will be drawn, including high-sensitivity C-reactive protein, serum homocysteine.
Ophthalmology examination will include a review of symptoms, examination, and fundus imaging.
The examination will consist of visual acuity testing, refraction testing, retinoscopy, ocular pressure, and examination under mydriasis.
Fundus photography will be used to capture an image of the retina for examination of potential hypertensive retinopathy.
|
연구는 무엇을 측정합니까?
주요 결과 측정
결과 측정 |
측정값 설명 |
기간 |
|---|---|---|
|
Neurocognitive measures of sustained attention and memory between HL survivor group and control group.
기간: Once, at or near enrollment
|
To evaluate brain integrity in adult survivors of childhood cancer treated with thoracic radiation therapy. Two-sided two-sample t test will be conducted to compare the difference of neurocognitive impairment in area of sustained attention and memory in the HL survivors and matched controls. |
Once, at or near enrollment
|
|
Rate of leukoencephalopathy and hemosiderin deposits on quantitative MRI between HL survivor group and control group.
기간: Once, at or near enrollment
|
To evaluate brain integrity in adult survivors of childhood cancer treated with thoracic radiation therapy. Two-sided two-sample proportional test will be used to compare the rates of leukoencephalopathy and hemosiderin deposits between in the HL survivors and matched controls. |
Once, at or near enrollment
|
|
Rate of neurologic symptoms between HL survivor group and control group.
기간: Once, at or near enrollment
|
To evaluate brain integrity in adult survivors of childhood cancer treated with thoracic radiation therapy. Two-sided two-sample proportional test will be used to compare the rates of neurologic symptoms between the HL survivors and matched controls. |
Once, at or near enrollment
|
2차 결과 측정
결과 측정 |
측정값 설명 |
기간 |
|---|---|---|
|
Association between thoracic radiation dose and sustained attention and memory scores and rate of leukoencephalopathy and hemosiderin deposits in HL survivors.
기간: Once, at or near enrollment
|
In HL survivors only, outcome variables will be: sustained attention (continuous), memory (continuous), leukoencephalopathy (dichotomous) and hemosiderin deposits (dichotomous).
Independent variables are radiation dose to cardiopulmonary structures.
Covariates will include chemotherapy exposures, particularly anthracycline exposure.
For each continuous response variable, linear regression model will be used to see its association with these independent variables, adjusted for race/age/sex.
Other possible covariates include educational attainment, employment and occupation, current physical activity, and alcohol and tobacco.
For each dichotomous response variable, logistic regression model will be used to see its association with these independent variables, adjusted for race/age/sex.
AIC criteria will be used to select the final model.
|
Once, at or near enrollment
|
|
Association between cardiac, vascular and pulmonary health and sustained attention and memory scores and rate of leukoencephalopathy and hemosiderin deposits.
기간: Once, at or near enrollment
|
In HL survivors only, outcome variables will be: sustained attention (continuous), memory (continuous), leukoencephalopathy (dichotomous) and hemosiderin deposits (dichotomous).
Independent variables are cardiac, vascular and pulmonary health.
For each continuous response variable, linear regression model will be used to see its association with these independent variables, adjusted for race/age/sex.
Other possible covariates include educational attainment, employment and occupation, current physical activity, and alcohol and tobacco.
For each dichotomous response variable, logistic regression model will be used to see its association with these independent variables, adjusted for race/age/sex.
AIC criteria will be used to select the final model.
|
Once, at or near enrollment
|
공동 작업자 및 조사자
간행물 및 유용한 링크
연구 기록 날짜
연구 주요 날짜
연구 시작 (실제)
기본 완료 (실제)
연구 완료 (실제)
연구 등록 날짜
최초 제출
QC 기준을 충족하는 최초 제출
처음 게시됨 (추정)
연구 기록 업데이트
마지막 업데이트 게시됨 (실제)
QC 기준을 충족하는 마지막 업데이트 제출
마지막으로 확인됨
추가 정보
이 연구와 관련된 용어
기타 연구 ID 번호
- BRIGHT (기타 식별자: Alias Study Number)
- R01CA174794 (미국 NIH 보조금/계약)
약물 및 장치 정보, 연구 문서
미국 FDA 규제 의약품 연구
미국 FDA 규제 기기 제품 연구
이 정보는 변경 없이 clinicaltrials.gov 웹사이트에서 직접 가져온 것입니다. 귀하의 연구 세부 정보를 변경, 제거 또는 업데이트하도록 요청하는 경우 register@clinicaltrials.gov. 문의하십시오. 변경 사항이 clinicaltrials.gov에 구현되는 즉시 저희 웹사이트에도 자동으로 업데이트됩니다. .
호지킨 림프종에 대한 임상 시험
-
National Cancer Institute (NCI)완전한재발성 성인 Hodgkin 림프종 | III기 성인 Hodgkin 림프종 | IV기 성인 Hodgkin 림프종 | 재발성/불응성 소아 호지킨 림프종 | III기 소아기 호지킨 림프종 | IV기 소아기 호지킨 림프종 | I기 성인 Hodgkin 림프종 | 1기 소아기 호지킨 림프종 | II기 성인 Hodgkin 림프종 | II기 소아기 호지킨 림프종 | 소아 결절성 림프구 우세형 Hodgkin 림프종 | 성인 림프구 고갈 호지킨 림프종 | 성인 림프구 우세형 Hodgkin 림프종 | 성인 혼합 세포성 Hodgkin 림프종 | 성인 결절성 경화증 호지킨 림프종 | 성인 결절성 림프구 우세형... 그리고 다른 조건미국
-
Northwestern UniversitySeagen Inc.; Robert H. Lurie Cancer Center알려지지 않은III기 성인 Hodgkin 림프종 | IV기 성인 Hodgkin 림프종 | II기 성인 Hodgkin 림프종 | 성인 림프구 고갈 호지킨 림프종 | 성인 림프구 우세형 Hodgkin 림프종 | 성인 혼합 세포성 Hodgkin 림프종 | 성인 결절성 경화증 호지킨 림프종미국
-
Northwestern UniversityNational Cancer Institute (NCI); Merck Sharp & Dohme LLC모집하지 않고 적극적으로림프구가 풍부한 고전적 Hodgkin 림프종 | 재발성 림프구 고갈 고전적 Hodgkin 림프종 | 재발성 혼합 세포질 고전적 Hodgkin 림프종 | 재발성 결절 경화증 고전적 호지킨 림프종 | 난치성 림프구 고갈 고전적 Hodgkin 림프종 | 불응성 혼합 세포질 고전적 Hodgkin 림프종 | 난치성 결절 경화증 고전적 Hodgkin 림프종미국
-
Mayo Clinic빼는호지킨 림프종 | III기 성인 Hodgkin 림프종 | IV기 성인 Hodgkin 림프종 | I기 성인 Hodgkin 림프종 | II기 성인 Hodgkin 림프종미국
-
Stanford UniversityMerck Sharp & Dohme LLC모병호지킨 림프종 | 전형적인 Hodgkin 림프종 | 난치성 고전적 Hodgkin 림프종 | 재발성 고전적 Hodgkin 림프종미국
-
National Cancer Institute (NCI)모집하지 않고 적극적으로앤아버 III기 호지킨 림프종 | 앤아버 III기 림프구 고갈 고전적 Hodgkin 림프종 | 앤아버 III기 혼합 세포질 전형적인 Hodgkin 림프종 | 앤아버 III기 결절성 경화증 고전적 Hodgkin 림프종 | 앤아버 IV기 호지킨 림프종 | 앤아버 IV기 림프구 고갈된 전형적인 Hodgkin 림프종 | 앤아버 IV기 혼합 세포질 전형적인 Hodgkin 림프종 | 앤아버 4기 결절 경화증 고전적 호지킨 림프종 | 전형적인 Hodgkin 림프종 | 림프구가 풍부한 고전적 Hodgkin 림프종미국, 캐나다, 푸에르토 리코
-
Beth Christian완전한재발성 성인 Hodgkin 림프종 | 성인 림프구 고갈 호지킨 림프종 | 성인 림프구 우세형 Hodgkin 림프종 | 성인 혼합 세포성 Hodgkin 림프종 | 성인 결절성 경화증 호지킨 림프종 | 성인 결절성 림프구 우세형 Hodgkin 림프종미국
-
National Cancer Institute (NCI)완전한재발성 성인 Hodgkin 림프종 | 성인 림프구 고갈 호지킨 림프종 | 성인 림프구 우세형 Hodgkin 림프종 | 성인 혼합 세포성 Hodgkin 림프종 | 성인 결절성 경화증 호지킨 림프종 | 성인 결절성 림프구 우세형 Hodgkin 림프종 | Adult Favorable Prognosis Hodgkin Lymphoma | Adult Unfavorable Prognosis Hodgkin Lymphoma미국
-
Northwestern UniversityNational Cancer Institute (NCI); Merck Sharp & Dohme LLC모집하지 않고 적극적으로고전적 Hodgkin 림프종 | 림프구 고갈 고전적 Hodgkin 림프종 | 림프구가 풍부한 고전적 Hodgkin 림프종 | 혼합 세포성 고전적 Hodgkin 림프종 | 결절성 경화증 고전적 호지킨 림프종미국
-
Ohio State University Comprehensive Cancer CenterNovartis; Celgene완전한재발성 성인 Hodgkin 림프종 | 성인 림프구 고갈 호지킨 림프종 | 성인 림프구 우세형 Hodgkin 림프종 | 성인 혼합 세포성 Hodgkin 림프종 | 성인 결절성 경화증 호지킨 림프종 | 성인 결절성 림프구 우세형 Hodgkin 림프종미국
Neurocognitive Evaluation에 대한 임상 시험
-
Memorial Sloan Kettering Cancer CenterComprehensive Cancer Centre The Netherlands모병